Gone, thankfully, are the days of million-dollar workstations whose end products, 3D figurines, looked more like Visible Man models than radiologic reconstructions. Not that they weren’t impressive. They were, rotating as they did, on color screens when gray scale was in vogue. But they were as clinically useful as they were dramatic.
Gone, thankfully, are the days of million-dollar workstations whose end products, 3D figurines, looked more like Visible Man models than radiologic reconstructions. Not that they weren’t impressive. They were, rotating as they did, on color screens when gray scale was in vogue. But they were as clinically useful as they were dramatic.
Today 3D reconstructions bring value to patient assessments, as will be seen Wednesday, May 19, during the Workstation Face-Off, as well as in numerous and varied presentations throughout the ISCT Symposium. All the more impressive is how many tedious and difficult tasks, from bone subtraction to soft tissue segmentation, are automatically performed. The operator now fine tunes the reconstruction, adding medical insights through the application of software tools. Of course, before this can be done, operators must be trained.
Vital Images is among the workstation companies that have inaugurated formal training programs. Its “ViTAL U” program teaches the fundamentals of advanced visualization, usually in a classroom designed for lecture and training, sometimes onsite for customers who cannot get to ViTAL U in Minnesota, and occasionally online.
The company indulged me in the latter opportunity, one that proved even a journalist with no prior training in graphic arts could create a 3D rendition from CT data with less than 10 minutes’ instruction .
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.